Gastrointestinal Cancer News

The novel HER2-targeted antibody-drug conjugate fam-trastuzumab deruxtecan-nxki appeared active in a cohort of patients with various heavily pretreated HER2-expressing or HER2-mutant solid tumors, according to results of a dose-expansion study published in Cancer Discovery.

The FDA has granted orphan drug designation to therapies for six hematology/oncology drug indications.

Primary liver cancer rates continue to increase in many regions of the world despite extensive efforts to prevent the disease, according to study results published in Cancer.

Increases in the proportion of patients diagnosed with pancreatic cancer at an earlier stage and younger age may be due to improvements in early detection and diagnosis, according to study results published in Journal of National Cancer Institute.

Patients with cancer may experience more than double the risk for atrial fibrillation compared with the general population.

Cancer death rates declined between 2001 and 2017 in the United States for all cancer sites combined, according to the Annual Report to the Nation on the Status of Cancer published in Cancer.

Low-dose aspirin use appeared associated with significantly lower risk for hepatocellular carcinoma and lower liver-related mortality among patients with chronic viral hepatitis, according to results of a retrospective study published in The New England Journal of Medicine.

The FDA granted accelerated approval to nivolumab plus ipilimumab for treatment of patients with hepatocellular carcinoma who previously received sorafenib.

Karyn Aalami Goodman, MD, MS, has been appointed associate director for clinical research at The Tisch Cancer Institute, part of Icahn School of Medicine at Mount Sinai.

The burden of colorectal cancer has shifted considerably toward younger individuals over the past few decades, according to American Cancer Society’s Colorectal Cancer Statistics 2020 report published in CA: A Cancer Journal for Clinicians.